What's new

Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised

May 15, 2025 - 13:46
 0
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Riluzole Zentiva, rilu...

Next Article

Trump Touts Twin-Engine F-35 Variant Dubbed F-55

Related Posts

PRIME: priority medicines

PRIME: priority medicines

May 6, 2025  0

Who we are

Who we are

May 8, 2025  0

Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 7, 2025  0